Soleus Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.1M	Sell	521,353 -65,647	-11%	-$2.91M	1.02%	26
2025 Q4	$24.2M	Buy	587,000 +437,000	+291%	+$17.5M	1.03%	33
2025 Q3	$5.82M	Sell	150,000 -104,689	-41%	-$3.4M	0.31%	57
2025 Q2	$7.05M	Sell	254,689 -214,811	-46%	-$5.47M	0.49%	48
2025 Q1	$10.4M	Buy	+469,500	New	+$9.66M	0.82%	35
2024 Q4	–	Sell	-302,500	Closed	-$7.56M	–	97
2024 Q3	$7.56M	Buy	302,500 +102,500	+51%	+$2.5M	0.63%	46
2024 Q2	$3.73M	Buy	+200,000	New	+$3.75M	0.33%	68
2023 Q4	–	Sell	-157,349	Closed	-$2.73M	–	91
2023 Q3	$2.73M	Sell	157,349 -362,291	-70%	-$6.1M	0.28%	65
2023 Q2	$7.32M	Buy	+519,640	New	+$6.95M	0.81%	39